Jennifer Cochran
Director/Board Member at OMNIAB, INC.
Net worth: 405 261 $ as of 30/05/2024
Profile
Jennifer Cochran is the founder of Red Tree Venture Capital, founded in 2020.
She is also the founder of Switch Bioworks, Inc., founded in 2022, where she currently serves as a Board Advisor.
Dr. Cochran's current positions include Director at Revel Pharmaceuticals, Inc., Virsti Therapeutics, Inc., OmniAb Operations, Inc., Biograph 55, Inc., Rondo Therapeutics, Inc., and Stanford University, where she has been a Professor since 2005.
Additionally, she is an Independent Director and Independent Director at OmniAb, Inc. and Ligand Pharmaceuticals, Inc., respectively.
Dr. Cochran's former positions include Director at Combangio, Inc. and Nodus Therapeutics, Inc., as well as Chief Scientist at Lagunita Biosciences LLC from 2015 to 2020.
She obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of Delaware.
Dr. Cochran is also the founder of xCella Biosciences, Inc...
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMNIAB, INC.
0.08% | 30/03/2024 | 93,378 ( 0.08% ) | 405 261 $ | 30/05/2024 |
Jennifer Cochran active positions
| Companies | Position | Start |
|---|---|---|
| OMNIAB, INC. | Director/Board Member | 31/10/2022 |
Revel Pharmaceuticals, Inc.
 Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Director/Board Member | - |
| Virsti Therapeutics, Inc. | Director/Board Member | - |
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Founder | 31/12/2019 |
Switch Bioworks, Inc.
 Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | Founder | 28/02/2022 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Director/Board Member | - |
| Stanford University | Corporate Officer/Principal | 31/12/2004 |
Biograph 55, Inc.
 Biograph 55, Inc. BiotechnologyHealth Technology Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh. | Director/Board Member | - |
Rondo Therapeutics, Inc.
 Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Director/Board Member | - |
Former positions of Jennifer Cochran
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Jennifer Cochran
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Private companies | 11 |
|---|---|
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Finance |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology xCella Biosciences, Inc. engages in the development of protein therapeutics for cancer treatment. Its pipeline is XC-201, a tumor targeting agent. The company was founded by Bob Chen and K. Dane Wittrup and is headquartered in Menlo Park, CA. | Health Technology |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Health Technology |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Finance |
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Combangio, Inc. operates as an investment holding company. The company was headquartered in Menlo Park, CA. | Commercial Services |
Biograph 55, Inc.
Biograph 55, Inc. BiotechnologyHealth Technology Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh. | Health Technology |
| Virsti Therapeutics, Inc. | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Commercial Services |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation. | Process Industries |
| Nodus Therapeutics, Inc. |
- Stock Market
- Insiders
- Jennifer Cochran
